Objetivo: Estimar el riesgo de morir por SARS-CoV-2 en el periodo febrero de 2020 a junio de 2022, en función de las desigualdades socioterritoriales existentes en la Ciudad de México. Material y métodos. Análisis retrospectivo de los datos de defunciones por SARS-CoV-2 en la población de la Ciudad de México entre febrero de 2020 y junio de 2022, según la colonia de residencia clasificada en muy bajo, bajo, medio, alto y muy alto desarrollo social, a partir del Índice de Desarrollo Social (IDS) propuesto por el Consejo de Evaluación de la Ciudad de México.
Resultados: Las defunciones por Covid-19 en las colonias con muy bajo y bajo desarrollo social representaron casi la mitad de los fallecimientos. La población residente en los territorios con peores condiciones socioterritoriales falleció, en promedio, 10 años más joven que la del estrato con mejor IDS.
Conclusiones: Las diferencias en el riesgo de morir por SARS-CoV-2 se asociaron a las condiciones socioterritoriales en las que residía la población fallecida. El riesgo de muerte por SARS-CoV-2 fue más alto para las personas residentes en colonias con muy bajo y bajo IDS. Estas diferencias se redujeron a partir de la tercera ola, lo que posiblemente se deba al inicio de la vacunación masiva en la Ciudad de México.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21149/16043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Social and Health Factors Related to Treatment Discontinuity in Chilean Adults with Chronic Diseases During the COVID-19 Pandemic].
Rev Med Chil
October 2024
Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Unlabelled: A collateral effect of the COVID-19 pandemic has been the discontinuity of treatments, a highly sensitive situation for chronic patients.
Aim: to describe the factors associated with discontinuing treatments in chronic patients over 18 years old residing in Chile during the COVID-19 pandemic.
Methods: A secondary analysis of the database of the MOVID-IMPACT-C survey, which corresponds to a cross-sectional study with national urban representativeness, was carried out in 2020.
Advancing diagnostics with BODIPY-bismuthene DNA biosensors.
Nanoscale
March 2025
Departamento de Química Analítica y Análisis Instrumental, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
In this work, an electrochemical biosensor is prepared based on few-layer bismuthene hexagons (FLBHs) and a water-soluble BODIPY (BDP) derivative (BDP-NaSO) for early infection diagnosis. In particular, the detection in advance of a virus sequence in nasopharyngeal swab samples was developed. The combination of the FLBHs and BDP-NaSO facilitates the direct, sensitive, and specific detection of gene viruses without the need for any prior amplification step.
View Article and Find Full Text PDFInfluence of SARS-CoV-2 infection on the use of ceftazidime-avibactam in the critical patient.
Farm Hosp
February 2025
Servicio de Farmacia, Hospital Universitario 12 de Octubre, Madrid, España.
Objective: The objective of the study was to analyse possible changes in antibiotic policy with ceftazidime-avibactam during the SARS-CoV-2 pandemic in an Intensive Care Unit (ICU) to determine patient mortality 28 days after initiation of antimicrobial therapy and to describe the microorganisms that most frequently colonise critically ill patients.
Material And Method: Observational, single-centre, cohort study that included patients on treatment with ceftazidime-avibactam in ICU between March 2020 and September 2021. Demographic (age, sex), microbiological (colonisation, microorganisms isolated in blood cultures), pharmacotherapeutic (duration of treatment with ceftazidime-avibactam, antimicrobials used in synergy with ceftazidime-avibactam) and clinical (mortality, length of hospital stay and comorbidities) variables were collected.
[Validated clinical prediction model for mortality from COVID-19 in hospitalized patients. What is truly important?].
Semergen
February 2025
Servicio de Medicina Interna, Unidad de Investigación, Hospital Universitario de Guadalajara, Guadalajara, España; Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, IDISCAM, Madrid, España.
Objective: To develop and validate a clinical prediction model aimed at improving resource management and determining the prognosis of patients hospitalized with COVID-19.
Materials And Methods: A retrospective, single-center cohort study conducted at the University Hospital of Guadalajara, including 1,043 patients hospitalized with COVID-19 between March and May 2020. Data were extracted from hospital records and anonymized.
Recovery of cardiovascular testing in Asia during the COVID-19 pandemic: findings from the INCAPS COVID 2 study.
Open Heart
February 2025
Seymour, Paul and Gloria Milstein Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University, New York, New York, USA
Background: Understanding pandemic-related reductions and subsequent recovery of cardiovascular testing in Asia is important for guiding regional public health efforts.
Objectives: This study sought to evaluate the recovery of cardiovascular testing in Asia 1 year into the COVID-19 pandemic.
Methods: In this subanalysis of a worldwide survey on the impact of COVID-19 on cardiovascular diagnostic care in April 2020 and April 2021, recovery of testing volume in Asia was compared among subregions, World Bank income groups and imaging modalities.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!